Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Stanford University
Collaborators
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT06309563 · Obesity Morbid, Weight Loss
NCT04036331 · Weight Loss, Pediatric Obesity, and more
NCT00739362 · Electric Stimulation Therapy, Obesity, and more
NCT06989203 · Obesity, Weight Loss, and more
Stanford
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions